COMMUNIQUÉS West-GlobeNewswire

Novartis presents new data at SABCS across broad range of breast cancer patient populations, combination treatments and lines of therapy
14/11/2017
Presentation of results from the Kisqali ® (ribociclib) MONALEESA-7 Phase III trial exclusively studying premenopausal women with HR+/HER2- advanced breast cancer New MONALEESA-2 analyses focused on quality of life, [...]
New data reinforces clinical basis for switching to Sandoz biosimilar medicines
14/11/2017
Sandoz strengthens position as global leader in biosimilars with new immunology data from four clinical studies for proposed biosimilars adalimumab and rituximab Efficacy and safety of biosimilar adalimumab and safety [...]
Targovax to present at upcoming investor conferences
14/11/2017
Oslo, Norway, 14 November 2017 - Targovax ASA (OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, announces that members of its senior management will present at [...]
Tel Aviv District Court Ordered MediWound to Purchase Approximately $1.5 Million of PolyHeal Shares; MediWound Weighing an Appeal
14/11/2017
YAVNE, Israel, Nov. 13, 2017 (GLOBE NEWSWIRE) -- MediWound Ltd. (NASDAQ: MDWD ), a fully-integrated biopharmaceutical company specializing in innovative therapies to address unmet needs in severe burn and wound [...]
MolecularMD to Implement Promega’s Microsatellite Instability (MSI) Technology for Immuno-Oncology Applications
14/11/2017
PORTLAND, Ore. and CAMBRIDGE, Mass., Nov. 13, 2017 (GLOBE NEWSWIRE) -- MolecularMD announces that it has now become a Preferred Provider of Promega’s Microsatellite Instability (MSI) v1.2 Analysis System. MolecularMD [...]
CORRECTING and REPLACING -- Celsion Files Immunotherapy Clinical Protocol for the Evaluation of GEN-1 to Treat Newly Diagnosed Ovarian Cancer
14/11/2017
Expert Advisory Board Endorses Randomized Phase I/II Trial in Newly Diagnosed Stage III and IV Ovarian Cancer GEN-1 Immunotherapy to Enter Phase I/II Clinical Study in the First Half of 2018 Following a Phase IB Trial [...]
MyoKardia Presents Data from Study of Machine Learning Algorithm Intended to Identify Obstructive Hypertrophic Cardiomyopathy Using a Wearable Biosensor
14/11/2017
SOUTH SAN FRANCISCO, Calif., Nov. 13, 2017 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK ), a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable [...]
Arbutus’ LNP Licensee Alnylam Receives Accelerated Assessment of Patisiran from European Medicines Agency (EMA)
13/11/2017
VANCOUVER, British Columbia and WARMINSTER, Pa., Nov. 13, 2017 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS ), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, announced [...]
Celsion Files Immunotherapy Clinical Protocol for the Evaluation of GEN-1 to Treat Newly Diagnosed Ovarian Cancer
13/11/2017
Expert Advisory Board Endorses Randomized Phase I/II Trial in Newly Diagnosed Stage III and IV Ovarian Cancer GEN-1 Immunotherapy to Enter Phase I/II Clinical Study in the First Half of 2018 Following a Phase IB Trial [...]
Canada House Wellness Group provides Bi-Weekly Update on Status of Management Cease Trade Order
13/11/2017
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Nov. 13, 2017 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (CSE:CHV) (“ Canada House ” or the “ Company ”) wishes to [...]
OnePoint Patient Care and Hospice by the Bay Partner to Provide Dedicated Hospice Pharmacy Services in Northern California
13/11/2017
MORTON GROVE, Ill., Nov. 13, 2017 (GLOBE NEWSWIRE) -- OnePoint Patient Care, the leader in national hospice PBM and pharmacy services, announced its partnership with Hospice by the Bay, a leading not-for-profit hospice [...]
Royal Adelaide Hospital goes live with Allscripts EHR solution
13/11/2017
ADELAIDE, Australia, Nov. 13, 2017 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX ) is in partnership with South Australia Health to deliver the Allscripts Sunrise™ product suite across the state of South Australia. The [...]
Clearside Biomedical, Inc. to Participate in Stifel 2017 Healthcare Conference
13/11/2017
ALPHARETTA, Ga., Nov. 13, 2017 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ: CLSD ), a late-stage clinical biopharmaceutical company developing first-in-class drug therapies to treat back-of-the-eye diseases, [...]
Royal Adelaide Hospital goes live with Allscripts EHR solution
13/11/2017
ADELAIDE, Australia, Nov. 13, 2017 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX ) is in partnership with South Australia Health to deliver the Allscripts Sunrise™ product suite across the state of South Australia. The [...]
Vascepa® (Icosapent Ethyl) Showed Reductions in Potentially Atherogenic Lipid and Inflammatory Markers in Statin Treated Patients With Persistent High Triglycerides and Chronic Kidney Disease
13/11/2017
BEDMINSTER, N.J. and DUBLIN, Ireland, Nov. 13, 2017 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN ), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve [...]
Acura Pharmaceuticals Announces Third Quarter 2017 Financial Results
13/11/2017
PALATINE, Ill., Nov. 13, 2017 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB:ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, announced today financial results for the three and nine [...]
Precipio, Inc. Announces Closing of $2,748,000 Registered Direct Offering
13/11/2017
NEW HAVEN, Conn., Nov. 13, 2017 (GLOBE NEWSWIRE) -- Precipio, Inc. (NASDAQ: PRPO ), announced today that it has completed a registered direct offering for the purchase and sale of 2,748 units, each consisting of one [...]
Akcea Initiates AKCEA-ANGPTL3-LRx Phase 2 Program in Patients with Rare Hyperlipidemias
13/11/2017
CAMBRIDGE, Mass., Nov. 13, 2017 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ: AKCA ), an affiliate of Ionis Pharmaceuticals, Inc. (NASDAQ: IONS ), focused on developing and commercializing drugs to treat [...]
BeiGene Reports Third Quarter 2017 Financial Results
13/11/2017
CAMBRIDGE, Mass. and BEIJING, China, Nov. 13, 2017 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE ), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly [...]

Pages